| Hannah Michaella Wood, OD | |
|
1 Va Center, Surgical Service 112 E, Augusta, ME 04330 | |
| (207) 623-8411 | |
| Not Available |
| Full Name | Hannah Michaella Wood |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 4 Years |
| Location | 1 Va Center, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154936920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPT1033 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dale Rodrigue Eye Care Center Inc | 5799097580 | 2 |
News Archive
Under the health law, states are required to let the Department of Health and Human Services know by Nov. 16 if they plan to set up their own exchanges or enter into a state-federal partnership.
Researchers have demonstrated, for the first time, a graphene-based transistor array that is compatible with living biological cells and capable of recording the electrical signals they generate.
The government is weighing whether to cut Medicare payments to physicians who use medical-imaging machines to screen patients for diseases like cancer and heart problems. The decision could come as early as Friday. Lawmakers and the Centers for Medicare and Medicaid Services see the cuts as a way to prevent overuse of the technology, which drives up health care costs.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Provider Name | Dale Rodrigue Eye Care Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1841587656 PECOS PAC ID: 5799097580 Enrollment ID: O20150708001041 |
News Archive
Under the health law, states are required to let the Department of Health and Human Services know by Nov. 16 if they plan to set up their own exchanges or enter into a state-federal partnership.
Researchers have demonstrated, for the first time, a graphene-based transistor array that is compatible with living biological cells and capable of recording the electrical signals they generate.
The government is weighing whether to cut Medicare payments to physicians who use medical-imaging machines to screen patients for diseases like cancer and heart problems. The decision could come as early as Friday. Lawmakers and the Centers for Medicare and Medicaid Services see the cuts as a way to prevent overuse of the technology, which drives up health care costs.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Michaella Wood, OD 35 Borskis Way, Wiscasset, ME 04578-4715 Ph: () - | Hannah Michaella Wood, OD 1 Va Center, Surgical Service 112 E, Augusta, ME 04330 Ph: (207) 623-8411 |
News Archive
Under the health law, states are required to let the Department of Health and Human Services know by Nov. 16 if they plan to set up their own exchanges or enter into a state-federal partnership.
Researchers have demonstrated, for the first time, a graphene-based transistor array that is compatible with living biological cells and capable of recording the electrical signals they generate.
The government is weighing whether to cut Medicare payments to physicians who use medical-imaging machines to screen patients for diseases like cancer and heart problems. The decision could come as early as Friday. Lawmakers and the Centers for Medicare and Medicaid Services see the cuts as a way to prevent overuse of the technology, which drives up health care costs.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
› Verified 3 days ago
Dr. James P Smith, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Va Ctr, Togus Vamc Eye Clinic, Augusta, ME 04330 Phone: 207-623-8411 | |
Smart Vision, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 255 Western Ave, Augusta, ME 04330 Phone: 207-622-5800 Fax: 207-621-2790 | |
Benjamin I Graham, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Dr. Stephanie Lynn Arnio, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 | |
Advanced Vision Care Of Maine Optometrist Medicare: Medicare Enrolled Practice Location: 254 Western Ave, Augusta, ME 04330 Phone: 207-622-3015 Fax: 207-621-7716 | |
Dr. Leah D Grotton, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 58 State St, Augusta, ME 04330 Phone: 207-623-5099 Fax: 207-623-7124 |